Literature DB >> 9808095

Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol.

S Hahn1, N B Kuemmerle, W Chan, S Hisano, P Saborio, R J Krieg, J C Chan.   

Abstract

Glomerulosclerosis and tubulointerstitial injury are characteristic features seen in the subtotal (5/6) nephrectomy remnant kidney model in the rat. Oxidative stress from renal mass reduction contributes to the glomerular and tubular injury. Previous studies have clearly demonstrated the prevention or inhibition of such injury by an antioxidant such as alpha-tocopherol. However, few data are available on the ability of alpha-tocopherol to modulate or arrest progression of the established disease. This study examines whether alpha-tocopherol modulates glomerulosclerosis and tubulointerstitial injury when it is given 2 wk after renal damage has been established. The findings indicate that alpha-tocopherol has the capacity to modulate both tubulointerstitial injury and glomerulosclerosis, lower the elevated expression of transforming growth factor-beta1, and reduce plasma and kidney malondialdehyde concentration, the end product of lipid peroxidation. The results support the potential utility of alpha-tocopherol in reversing established glomerulosclerosis and tubulointerstitial injury in a remnant kidney model.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808095     DOI: 10.1681/ASN.V9112089

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

1.  Aqueous extract of Annona squamosa (L.) ameliorates renal failure induced by 5/6 nephrectomy in rat.

Authors:  Aaishwarya B Deshmukh; Jayvadan K Patel
Journal:  Indian J Pharmacol       Date:  2011-11       Impact factor: 1.200

2.  Dietary supplements of vitamins E and C and beta-carotene reduce oxidative stress in cats with renal insufficiency.

Authors:  S Yu; I Paetau-Robinson
Journal:  Vet Res Commun       Date:  2006-05       Impact factor: 2.459

Review 3.  Reactive oxygen species: roles in blood pressure and kidney function.

Authors:  Christopher S Wilcox
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 4.  Liposoluble vitamins A and E in kidney disease.

Authors:  Maria Helena Rojo-Trejo; Ma Ludivina Robles-Osorio; Ernesto Sabath
Journal:  World J Nephrol       Date:  2022-05-25

5.  Renal Denervation Improves the Baroreflex and GABA System in Chronic Kidney Disease-induced Hypertension.

Authors:  Hsin-Hung Chen; Pei-Wen Cheng; Wen-Yu Ho; Pei-Jung Lu; Chi-Cheng Lai; Yang-Ming Tseng; Hua-Chang Fang; Gwo-Ching Sun; Michael Hsiao; Chun-Peng Liu; Ching-Jiunn Tseng
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

6.  Urinary F2 -Isoprostanes in Cats with International Renal Interest Society Stage 1-4 Chronic Kidney Disease.

Authors:  W Whitehouse; J Quimby; S Wan; K Monaghan; R Robbins; L A Trepanier
Journal:  J Vet Intern Med       Date:  2017-02-04       Impact factor: 3.333

7.  The Effects of Long-Term Chaetomellic Acid A Administration on Renal Function and Oxidative Stress in a Rat Model of Renal Mass Reduction.

Authors:  António Nogueira; Francisco Peixoto; Maria Manuel Oliveira; Carlos André Pires; Bruno Colaço; Paula Alexandra Oliveira; Maria João Pires
Journal:  Biomed Res Int       Date:  2017-02-23       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.